Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate


Thursday, March 5, 2015

Pakistan: Hepatitis C medication: Govt slashes Sovaldi’s price

ISLAMABAD: The federal government on Wednesday announced a reduction in the price of Sovaldi — the ‘breakthrough drug’ for Hepatitis C. State minister for health Saira Tarar announced that the current price of Rs55,000 has been slashed and the drug would now be available at Rs32,300 per bottle, according to a press release. Tarar said the measure will benefit over 10 million Hepatitis C patients across Pakistan and the ministry will ensure that an adequate quantity of the drug is available within six weeks.
Published in The Express Tribune, March 5th, 2015.

Read more...
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)